In vitro and in vivo evaluation of carbamazepine-PEG 6000 solid dispersions
- 31 July 2001
- journal article
- Published by Elsevier BV in International Journal of Pharmaceutics
- Vol. 225 (1-2), 49-62
- https://doi.org/10.1016/s0378-5173(01)00741-4
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Physicochemical properties and bioavailability of carbamazepine polymorphs and dihydrateInternational Journal of Pharmaceutics, 1999
- Enhancement of carbamazepine dissolution: in vitro and in vivo evaluationInternational Journal of Pharmaceutics, 1998
- Simultaneous Determination of Carbamazepine and Carbamazepine 10,11-Epoxide by Using Microcolumn HPLC: Study of Pharmacokinetics of Carbamazepine in a VolunteerBiomedical Chromatography, 1997
- Improvement of the dissolution kinetics of SR 33557 by means of solid dispersions containing PEG 6000International Journal of Pharmaceutics, 1995
- Physicochemical characterization and dissolution of norfloxacin/cyclodextrin inclusion compounds and PEG solid dispersionsInternational Journal of Pharmaceutics, 1995
- Formulation and in Vitro — In Vivo Characterization of Solid Dispersions of PiroxicamDrug Development and Industrial Pharmacy, 1993
- Solubility and Dissolution of Etoposide from Solid Dispersions of PEG 8000Drug Development and Industrial Pharmacy, 1993
- Dissolution Rates of Carbamazepine and Nitrazepam Utilizing Sugar Solid Dispersion SystemDrug Development and Industrial Pharmacy, 1985
- Formation of dihydrate from carbamazepine anhydrate in aqueous conditionsInternational Journal of Pharmaceutics, 1984
- The effect of composition and ageing on the dissolution rates of chlorpropamide-urea solid dispersionsJournal of Pharmacy and Pharmacology, 1977